Pertussis and Meningitis C Concomitant Vaccination in Adolescents
Status:
Completed
Trial end date:
2017-03-31
Target enrollment:
Participant gender:
Summary
The trial includes groups receiving various combinations of meningitis C and pertussis
containing vaccines, to be administered concomitantly in adolescents due their school leaving
booster vaccinations (as per UK routine immunisation schedule at 13-17 years of age).
Immunogenicity and reactogenicity will be assessed.